Elevance Health (ELV) | Financial Analysis & Statements
Elevance Health Inc. Large-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
49.7B
Net Income
546.0M
1.10%
EPS (Diluted)
$2.47
Balance Sheet Metrics
Total Assets
121.5B
Total Liabilities
77.5B
Shareholders Equity
44.0B
Debt to Equity
1.76
Cash Flow Metrics
Operating Cash Flow
-1.4B
Free Cash Flow
-209.0M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Elevance Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 199.1B | 176.8B | 171.3B | 156.6B | 138.6B |
| Cost of Goods Sold | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | 17.7B | 15.9B |
| Other Operating Expenses | 42.2B | 39.8B | 37.4B | 30.7B | 26.8B |
| Total Operating Expenses | 42.2B | 39.8B | 37.4B | 48.4B | 42.7B |
| Operating Income | - | - | - | - | - |
| Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 1.4B | 1.2B | 1.0B | 851.0M | 798.0M |
| Other Non-Operating Income | 24.5B | 22.6B | 19.5B | 15.0B | 12.7B |
| Pre-tax Income | 6.7B | 7.9B | 7.7B | 7.6B | 8.0B |
| Income Tax | 1.0B | 1.9B | 1.7B | 1.7B | 1.8B |
| Effective Tax Rate % | 15.6% | 24.5% | 22.3% | 22.5% | 23.1% |
| Net Income | 5.7B | 6.0B | 6.0B | 5.9B | 6.1B |
| Net Margin % | 2.8% | 3.4% | 3.5% | 3.8% | 4.4% |
| Key Metrics | |||||
| EBITDA | - | - | - | - | - |
| EPS (Basic) | $25.28 | $26.29 | $25.69 | $25.32 | $25.25 |
| EPS (Diluted) | $25.21 | $25.68 | $25.22 | $24.81 | $24.73 |
| Basic Shares Outstanding | 224000000 | 227479695 | 233071088 | 237958067 | 241770746 |
| Diluted Shares Outstanding | 224000000 | 227479695 | 233071088 | 237958067 | 241770746 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Elevance Health Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 9.5B | 8.3B | 6.5B | 7.4B | 4.9B |
| Short-term Investments | 25.9B | 25.2B | 29.6B | 26.0B | 26.3B |
| Accounts Receivable | 10.1B | 8.0B | 7.9B | 7.1B | 5.7B |
| Inventory | - | - | - | - | - |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | - | - | - | - | - |
| Non-Current Assets | |||||
| Property, Plant & Equipment | - | - | - | - | - |
| Goodwill | 67.9B | 68.6B | 60.9B | 59.1B | 59.1B |
| Intangible Assets | 11.2B | 12.1B | 10.3B | 10.3B | 10.6B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | - | - | - | - | - |
| Total Non-Current Assets | - | - | - | - | - |
| Total Assets | 121.5B | 116.9B | - | - | - |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 24.4B | 22.7B | 23.0B | 21.2B | 18.5B |
| Short-term Debt | 1.2B | 2.0B | 1.9B | 1.8B | 1.9B |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | - | - | - | - | - |
| Non-Current Liabilities | |||||
| Long-term Debt | 30.8B | 29.2B | 23.2B | 22.3B | 21.2B |
| Deferred Tax Liabilities | 2.1B | 2.1B | 2.0B | 2.0B | 2.8B |
| Other Non-Current Liabilities | - | - | - | - | - |
| Total Non-Current Liabilities | - | - | - | - | - |
| Total Liabilities | 77.5B | 75.5B | - | - | - |
| Equity | |||||
| Common Stock | 2.0M | 2.0M | 2.0M | 2.0M | 2.0M |
| Retained Earnings | 35.4B | 33.5B | 31.7B | 29.6B | 27.1B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 44.0B | 41.4B | 39.4B | 36.3B | 36.1B |
| Key Metrics | |||||
| Total Debt | 32.0B | 31.2B | 25.1B | 24.1B | 23.0B |
| Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Elevance Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 5.7B | 6.0B | 6.0B | 5.9B | 6.1B |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | 276.0M | 191.0M | 289.0M | 264.0M | 255.0M |
| Working Capital Changes | -3.5B | 121.0M | -682.0M | -2.0B | -1.4B |
| Operating Cash Flow | 2.2B | 5.9B | 5.0B | 4.0B | 5.3B |
| Investing Activities | |||||
| Capital Expenditures | -1.1B | -1.3B | -1.3B | -1.2B | -1.1B |
| Acquisitions | 88.0M | -4.4B | -1.6B | -649.0M | -3.5B |
| Investment Purchases | -15.0B | -18.0B | -16.2B | -24.9B | -18.7B |
| Investment Sales | 15.1B | 18.6B | 13.5B | 22.6B | 14.6B |
| Investing Cash Flow | -1.3B | -5.2B | -5.6B | -4.6B | -9.6B |
| Financing Activities | |||||
| Share Repurchases | -2.6B | -2.9B | -2.7B | -2.3B | -1.9B |
| Dividends Paid | -1.5B | -1.5B | -1.4B | -1.2B | -1.1B |
| Debt Issuance | 3.0B | 7.7B | 2.6B | 3.1B | 3.5B |
| Debt Repayment | -3.9B | -2.4B | -2.2B | -3.6B | -2.5B |
| Financing Cash Flow | -3.5B | 274.0M | -3.7B | -3.5B | -2.2B |
| Free Cash Flow | 3.2B | 4.6B | 6.8B | 7.2B | 7.3B |
| Net Change in Cash | -2.7B | 1.0B | -4.3B | -4.0B | -6.5B |
Cash Flow Trend
Elevance Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
13.19
Forward P/E
11.44
Price to Book
1.67
Price to Sales
0.37
PEG Ratio
0.38
Profitability Ratios
Profit Margin
2.84%
Operating Margin
1.54%
Return on Equity
13.25%
Return on Assets
4.35%
Financial Health
Current Ratio
1.54
Debt to Equity
74.39
Beta
0.50
Per Share Data
EPS (TTM)
$25.20
Book Value per Share
$198.81
Revenue per Share
$888.96
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ELV | 76.4B | 13.19 | 1.67 | 13.25% | 2.84% | 74.39 |
| UnitedHealth | 322.3B | 26.81 | 3.42 | 12.18% | 2.68% | 73.98 |
| CVS Health | 101.1B | 55.65 | 1.31 | 2.29% | 0.44% | 106.06 |
| Cigna | 72.7B | 12.61 | 1.77 | 15.13% | 2.17% | 75.14 |
| Humana | 25.8B | 21.84 | 1.47 | 7.04% | 0.92% | 74.82 |
| Centene | 20.2B | 8.06 | 1.01 | -28.68% | -3.79% | 90.56 |
Financial data is updated regularly. All figures are in the company's reporting currency.






